510(k) K791354
K791354 is an FDA 510(k) premarket notification submitted by Amersham Corp. for the device "CODE QAS 103 ANTI-DNA CONTROLS". The FDA issued a decision of Substantially Equivalent on September 17, 1979. The device falls under product code KTL (Anti-Dna Indirect Immunofluorescent Solid Phase), a Class II device regulated under 21 CFR 866.5100. Amersham Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 17, 1979
- Date Received
- July 18, 1979
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Anti-Dna Indirect Immunofluorescent Solid Phase
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type